[go: up one dir, main page]

Phetsanthad et al., 2023 - Google Patents

Recent advances in mass spectrometry analysis of neuropeptides

Phetsanthad et al., 2023

View PDF
Document ID
2165965541687657991
Author
Phetsanthad A
Vu N
Yu Q
Buchberger A
Chen Z
Keller C
Li L
Publication year
Publication venue
Mass spectrometry reviews

External Links

Snippet

Due to their involvement in numerous biochemical pathways, neuropeptides have been the focus of many recent research studies. Unfortunately, classic analytical methods, such as western blots and enzyme‐linked immunosorbent assays, are extremely limited in terms of …
Continue reading at pmc.ncbi.nlm.nih.gov (PDF) (other versions)

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by the preceding groups
    • G01N33/48—Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6803—General methods of protein analysis not limited to specific proteins or families of proteins
    • G01N33/6848—Methods of protein analysis involving mass spectrometry
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by the preceding groups
    • G01N33/48—Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6803—General methods of protein analysis not limited to specific proteins or families of proteins
    • G01N33/6842—Proteomic analysis of subsets of protein mixtures with reduced complexity, e.g. membrane proteins, phosphoproteins, organelle proteins
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by the preceding groups
    • G01N33/48—Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
    • G01N33/5008—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics
    • G01N33/502—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics for testing non-proliferative effects
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by the preceding groups
    • G01N33/48—Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay
    • G01N33/558—Immunoassay; Biospecific binding assay using diffusion or migration of antigen or antibody
    • G01N33/561—Immunoelectrophoresis
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N27/00—Investigating or analysing materials by the use of electric, electro-chemical, or magnetic means
    • G01N27/26—Investigating or analysing materials by the use of electric, electro-chemical, or magnetic means by investigating electrochemical variables; by using electrolysis or electrophoresis
    • G01N27/416—Systems
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N30/00—Investigating or analysing materials by separation into components using adsorption, absorption or similar phenomena or using ion-exchange, e.g. chromatography or field flow fractionation
    • G01N30/02—Column chromatography
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00—Detection or diagnosis of diseases
    • G01N2800/28—Neurological disorders
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2500/00—Screening for compounds of potential therapeutic value

Similar Documents

Publication Publication Date Title
Phetsanthad et al. Recent advances in mass spectrometry analysis of neuropeptides
Brown et al. Top-down proteomics: challenges, innovations, and applications in basic and clinical research
Hellinger et al. Peptidomics
Buchberger et al. Advances in mass spectrometric tools for probing neuropeptides
Schey et al. Spatially-directed protein identification from tissue sections by top-down LC-MS/MS with electron transfer dissociation
Taus et al. Universal and confident phosphorylation site localization using phosphoRS
Johnson et al. On-capillary cell lysis enables top-down proteomic analysis of single mammalian cells by CE-MS/MS
Michalski et al. A systematic investigation into the nature of tryptic HCD spectra
Li et al. In Situ Sequencing of Peptides from Biological Tissues and Single Cells Using MALDI− PSD/CID Analysis
Jia et al. Site-specific characterization of D-amino acid containing peptide epimers by ion mobility spectrometry
Li et al. Peptides in the brain: mass spectrometry–based measurement approaches and challenges
Do et al. Single cell profiling using ionic liquid matrix-enhanced secondary ion mass spectrometry for neuronal cell type differentiation
Schrader Origins, technological development, and applications of peptidomics
Hart-Smith et al. Detection and characterization of low abundance glycopeptides via higher-energy C-trap dissociation and orbitrap mass analysis
Rubakhin et al. Profiling signaling peptides in single mammalian cells using mass spectrometry
Johnson et al. TMTpro complementary ion quantification increases plexing and sensitivity for accurate multiplexed proteomics at the MS2 level
Heijs et al. Comprehensive analysis of the mouse brain proteome sampled in mass spectrometry imaging
Khatri et al. Comparison of collisional and electron-based dissociation modes for middle-down analysis of multiply glycosylated peptides
Lietz et al. Large-scale collision cross-section profiling on a traveling wave ion mobility mass spectrometer
Winkels et al. Quantitative top-down proteomics by isobaric labeling with thiol-directed tandem mass tags
Vimer et al. Mass spectrometry analysis of intact proteins from crude samples
Tucholski et al. Fourier‐transform ion cyclotron resonance mass spectrometry for characterizing proteoforms
Chau et al. Glycomics-assisted glycoproteomics enables deep and unbiased N-glycoproteome profiling of complex biological specimens
Reid et al. Dissecting the structural heterogeneity of proteins by native mass spectrometry
Jung et al. Deuterium-free, three-plexed peptide diethylation for highly accurate quantitative proteomics